Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
S&P Global
SPGI
|
+$677M |
| 2 |
AGN
Allergan plc
AGN
|
+$437M |
| 3 |
Qualcomm
QCOM
|
+$387M |
| 4 |
lululemon athletica
LULU
|
+$366M |
| 5 |
NVIDIA
NVDA
|
+$330M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Under Armour
UAA
|
+$1.03B |
| 2 |
Abbott
ABT
|
+$767M |
| 3 |
MHFI
MCGRAW-HILL FINANCIAL INC COM
MHFI
|
+$627M |
| 4 |
Meta Platforms (Facebook)
META
|
+$520M |
| 5 |
Nike
NKE
|
+$454M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 19.26% |
| 2 | Healthcare | 16.99% |
| 3 | Technology | 15.48% |
| 4 | Communication Services | 12.63% |
| 5 | Financials | 9.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ANDV
526
DELISTED
Andeavor
ANDV
| $2.82M | ﹤0.01% |
37,700
+18,332
| +95% | +$1.45M |
|
527
General Dynamics
GD
$103B
| $2.68M | ﹤0.01% |
19,266
+4,840
| +34% | +$675K |
|
528
American Express
AXP
$225B
| $2.62M | ﹤0.01% |
+43,137
| New | +$2.73M |
|
529
Invesco
IVZ
$14.5B
| $2.6M | ﹤0.01% |
101,807
+33,533
| +49% | +$995K |
|
530
State Street SPDR S&P Metals & Mining ETF
XME
$4.74B
| $2.56M | ﹤0.01% |
105,241
-6,044
| -5% | -$136K |
|
531
Blackrock
BLK
$180B
| $2.47M | ﹤0.01% |
7,200
+3,206
| +80% | +$1.13M |
|
532
Markel Group
MKL
$22.5B
| $2.42M | ﹤0.01% |
2,545
-995
| -28% | -$927K |
|
533
Regenxbio
RGNX
$638M
| $2.34M | ﹤0.01% |
292,402
+14
| +0% | +$155 |
|
|
ALPN
534
DELISTED
Alpine Immune Sciences Inc
ALPN
| $2.27M | ﹤0.01% |
123,184
+4
| +0% | +$71 |
|
535
Stanley Black & Decker
SWK
$14.8B
| $2.23M | ﹤0.01% |
20,010
+5,176
| +35% | +$575K |
|
536
RLI Corp
RLI
$5.9B
| $2.19M | ﹤0.01% |
63,732
-992
| -2% | -$32.3K |
|
537
Danaher
DHR
$152B
| $2.09M | ﹤0.01% |
30,752
-1,815
| -6% | -$119K |
|
538
Amgen
AMGN
$234B
| $1.99M | ﹤0.01% |
+13,107
| New | +$2.04M |
|
539
Tyson Foods
TSN
$19.5B
| $1.98M | ﹤0.01% |
29,645
+11,201
| +61% | +$726K |
|
|
WBS
540
DELISTED
Webster Financial
WBS
| $1.95M | ﹤0.01% |
57,499
-3,739
| -6% | -$136K |
|
|
TIME
541
DELISTED
Time Inc.
TIME
| $1.92M | ﹤0.01% |
+116,809
| New | +$1.81M |
|
542
HF Sinclair
DINO
$17.7B
| $1.92M | ﹤0.01% |
80,875
-8,308
| -9% | -$247K |
|
543
Glacier Bancorp
GBCI
$6.1B
| $1.91M | ﹤0.01% |
71,789
-4,730
| -6% | -$123K |
|
544
United Natural Foods
UNFI
$2.77B
| $1.91M | ﹤0.01% |
40,743
-832,849
| -95% | -$32M |
|
545
Manhattan Associates
MANH
$13B
| $1.89M | ﹤0.01% |
29,390
-2,090
| -7% | -$130K |
|
|
SHLX
546
DELISTED
Shell Midstream Partners, L.P.
SHLX
| $1.89M | ﹤0.01% |
55,797
-885,338
| -94% | -$30.6M |
|
547
Altria Group
MO
$115B
| $1.85M | ﹤0.01% |
26,855
-1,241
| -4% | -$79.5K |
|
548
Plexus
PLXS
$6.42B
| $1.84M | ﹤0.01% |
42,555
-5,431
| -11% | -$229K |
|
|
AMED
549
DELISTED
Amedisys
AMED
| $1.79M | ﹤0.01% |
35,396
+23,681
| +202% | +$1.2M |
|
|
CMO
550
DELISTED
Capstead Mortgage Corp.
CMO
| $1.76M | ﹤0.01% |
181,193
-672,404
| -79% | -$6.55M |
|
Similar funds
Jennison Associates's Q2 2016 Portfolio in Review
As of Q2 2016, Jennison Associates held 691 positions worth $91.1B, down 4.3% from $95.3B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Jennison Associates withdrew a net $5.05B in Q2 2016, closing 61 positions and reducing 333 holdings. Its most notable exit was MCGRAW-HILL FINANCIAL INC COM, an estimated $627M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 19% of assets, down from 21% a quarter earlier, followed by Healthcare and Technology.
Against the trend, Jennison Associates opened a new position in S&P Global worth $677M.
- Jennison Associates's largest Q2 2016 buy was S&P Global: 6,307,763 shares worth $677M.
- Jennison Associates added most to Allergan plc in Q2 2016, an estimated $437M increase.
- Jennison Associates's biggest Q2 2016 reduction was Under Armour, cutting an estimated $1.03B.
- Jennison Associates fully exited MCGRAW-HILL FINANCIAL INC COM in Q2 2016, selling an estimated $627M.
- Jennison Associates's ten largest holdings make up 23% of its $91.1B portfolio in Q2 2016.
- Jennison Associates opened 83 new positions and closed 61 in Q2 2016.
- Jennison Associates's portfolio value fell 4.3% quarter-over-quarter to $91.1B.
Based on Jennison Associates's 13F filing for Q2 2016, filed 3 Aug 2016.